Skip to main content
QMSQMS
QMS
  • Welcome to your QMS
  • Quality Manual
  • Procedures
  • Records
  • Legit.Health Plus Version 1.1.0.0
  • Legit.Health Plus Version 1.1.0.1
  • Legit.Health version 2.1 (Legacy MDD)
  • Legit.Health Utilities
  • Licenses and accreditations
  • Applicable Standards and Regulations
  • BSI Non-Conformities
    • Technical Review
    • Clinical Review
      • Round 1
        • Item 0: Background & Action Plan
        • Item 1: CER Update Frequency
        • Item 2: Device Description & Claims
        • Item 3: Clinical Data
        • Item 4: Usability
        • Item 5: PMS Plan
        • Item 6: PMCF Plan
        • Item 7: Risk
        • MDCG 2020-13 & CER Template (reference)
          • MDCG 2020-13 (CEAR) sections
            • 00 Front matter, introduction, scope, approach
            • Section A — Administrative particulars
            • Section B — Reviewers involved in the notified body assessment
            • Section C (part 1) — Device description and classification
            • Section C (part 2) — CEP, information materials, common specifications, equivalence, state of the art
            • Section D — Clinical literature review
            • Section E — Clinical investigations and related documentation
            • Section F — PMS, PMCF and the plan for updates
            • Section G — IFU, SSCP, labelling and other information supplied with the device
            • Section I — Clinical evaluation consultation procedure (Article 54)
            • Section J — Where demonstration of conformity based on clinical data is not deemed appropriate (Article 61(10))
            • Section K — The voluntary clinical consultation on the clinical development strategy (Article 61(2))
            • Overall Conclusions
          • CER Template sections
        • Adequacy review
        • Coverage matrix
        • task-3b2-3b3-legacy-rwe-study
        • task-3b4-mrmc-dark-phototypes
  • Pricing
  • Public tenders
  • BSI Non-Conformities
  • Clinical Review
  • Round 1
  • MDCG 2020-13 & CER Template (reference)
  • MDCG 2020-13 (CEAR) sections
  • Section B — Reviewers involved in the notified body assessment

Section B — Reviewers involved in the notified body assessment

Source: MDCG-2020-01.pdf page 7 (document: MDCG 2020-13)

Section B: Reviewers involved in the notified body assessment of the clinical evaluation​

Provide the name or the employee code of the personnel with relevant clinical expertise (as per 3.2.4 of annex VII):

_____

Relevant clinical expertise:

_____

Have additional reviewers been involved?

  • Yes
  • No

Provide a justification:

_____

Additional reviewers assigned to review the clinical evaluation​

Number of additional reviewers / Names of additional reviewersSpecific aspects assessed (by each additional reviewer)Competence area / codes
Number of additional reviewers
Names of additional reviewers:
Separate the internal and external clinical reviewers.
You may use employee codes
For example, rationale for the design and chosen statistical methodology of clinical investigation etc.List of relevant MDR codes or area this person is authorised to, according to the Authorisation Matrix, as of Annex VII, 3.3.2)

Relevant expertise:
Previous
Section A — Administrative particulars
Next
Section C (part 1) — Device description and classification
  • Section B: Reviewers involved in the notified body assessment of the clinical evaluation
    • Additional reviewers assigned to review the clinical evaluation
All the information contained in this QMS is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI Labs Group S.L.)